Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Multiple Sclerosis
Related studies linked through entity extraction aliases.
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Randomised Controlled Clinical Trial of Cognitive Rehabilitation in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- NA
Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY)
- Status
- COMPLETED
- Phase
- N/A
Applications of Nanotechnology in Multiple Sclerosis by Respiratory Samples
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis
- Status
- TERMINATED
- Phase
- NA
Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Telehealth-Based Exercise Program to Treat Fatigue in MS
- Status
- COMPLETED
- Phase
- NA
A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly
- Status
- COMPLETED
- Phase
- PHASE2
Assessment of Patient Use of a New Device: RebiSmart
- Status
- COMPLETED
- Phase
- N/A
Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration
- Status
- COMPLETED
- Phase
- N/A
JC-virus (JCV) Epidemiology in Multiple Sclerosis (MS)
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS)
- Status
- COMPLETED
- Phase
- PHASE3
REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients
- Status
- COMPLETED
- Phase
- PHASE3
Zoledronic Acid in MS-patients With Osteoporosis
- Status
- TERMINATED
- Phase
- PHASE3
Early Cognitive Impairment in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance
- Status
- TERMINATED
- Phase
- N/A